Prana Biotechnology (ATHE)
(Delayed Data from NSDQ)
$2.01 USD
0.00 (0.00%)
Updated Jul 12, 2024 03:25 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for Prana Biotechnology Ltd falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -9.29 | -9.32 | -11.44 | -9.04 |
Depreciation/Amortization & Depletion | NA | 0.07 | 0.04 | 0.06 | 0.08 |
Net Change from Assets/Liabilities | NA | -4.30 | 1.28 | -3.21 | 2.80 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.04 | -0.95 | 1.65 | -0.17 |
Net Cash From Operating Activities | NA | -13.49 | -8.95 | -12.95 | -6.33 |
Property & Equipment | NA | 0.00 | -0.06 | -0.01 | -0.01 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | -0.02 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.02 | -0.06 | -0.01 | -0.01 |
Uses of Funds
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.21 | 12.46 | 29.32 | 2.93 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | -0.04 | -0.03 | -0.04 | -0.06 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.09 | -0.61 | -1.86 | -0.20 |
Net Cash from Financing Activities | NA | 0.08 | 11.83 | 27.41 | 2.67 |
Effect of Exchange Rate Changes | NA | 0.62 | 2.04 | -0.32 | 0.18 |
Net Change In Cash & Equivalents | NA | -12.81 | 4.85 | 14.14 | -3.49 |
Cash at Beginning of Period | NA | 23.43 | 20.40 | 6.87 | 9.67 |
Cash at End of Period | NA | 10.62 | 25.25 | 21.01 | 6.18 |
Diluted Net EPS | NA | -2.30 | -2.31 | -4.04 | -6.00 |
Fiscal Year End for Prana Biotechnology Ltd falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | NA | -4.24 | NA | -9.30 |
Depreciation/Amortization & Depletion | NA | NA | 0.05 | NA | 0.07 |
Net Change from Assets/Liabilities | NA | NA | 1.06 | NA | -4.30 |
Net Cash from Discontinued Operations | NA | NA | NA | NA | 0.00 |
Other Operating Activities | NA | NA | 0.21 | NA | 0.04 |
Net Cash From Operating Activities | NA | NA | -2.93 | NA | -13.49 |
Property & Equipment | NA | NA | 0.00 | NA | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | NA | NA | NA | 0.00 |
Investments | NA | NA | NA | NA | 0.00 |
Other Investing Activities | NA | NA | NA | NA | -0.02 |
Net Cash from Investing Activities | NA | NA | 0.00 | NA | -0.02 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | NA | 0.89 | NA | 0.21 |
Issuance (Repayment) of Debt | NA | NA | NA | NA | 0.00 |
Increase (Decrease) Short-Term Debt | NA | NA | -0.04 | NA | -0.04 |
Payment of Dividends & Other Distributions | NA | NA | NA | NA | 0.00 |
Other Financing Activities | NA | NA | -0.17 | NA | -0.09 |
Net Cash from Financing Activities | NA | NA | 0.68 | NA | 0.08 |
Effect of Exchange Rate Changes | NA | NA | 0.00 | NA | 0.62 |
Net Change In Cash & Equivalents | NA | NA | -2.25 | NA | -12.81 |
Cash at Beginning of Period | NA | NA | 10.28 | NA | 23.43 |
Cash at End of Period | NA | NA | 8.03 | NA | 10.62 |
Diluted Net EPS | NA | NA | NA | NA | NA |